Haemophilus influenza type b conjugate vaccine (Chengdu Institute of Biological Products)

b型流感嗜血杆菌结合疫苗（成都生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemophilus influenza type b conjugate vaccine (Chengdu Institute of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHaemophilus Infections

Global Approved IndicationsHaemophilus Infections

Approved Indications in ChinaHaemophilus Infections

Original Approved Country/TerritoryMainland China

Original Approved Date2013/06/03

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesChengdu Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsHaemophilus Infections

Inactive IndicationsN/A

Other Information

ATC CodeJ07AG01